---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-038977"
form_type: "8-K"
ticker: "ABSI"
cik: "0001672688"
company_name: "Absci Corp"
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:43:11.451367+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Absci partners with Almirall (up to $664M deal) and reports Q3 net loss of $22M

## Summary
- Entered AI drug partnership with Almirall for dermatology; up to $664M in milestones plus royalties for two programs.
- Q3 revenue fell to $0.7M from $2.4M YoY; net loss narrowed to $22.0M from $27.3M.
- Unveiled four wholly-owned AI drug assets (cytokine biology); first IND filing expected early 2025.
- Cash, equivalents, and short-term investments $113.5M; cash runway into late 2025.

## SEC filing metadata
- accession: 0001628280-23-038977
- form_type: 8-K
- ticker: ABSI
- cik: 0001672688
- company_name: Absci Corp
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672688/000162828023038977/0001628280-23-038977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672688/000162828023038977/absc-20231114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-038977
- JSON: https://secwatch.observer/filing/0001628280-23-038977.json
- Plain text: https://secwatch.observer/filing/0001628280-23-038977.txt

## Key facts
- Earnings Releases
  Absci Corp reported the quarter ended September 30, 2023 results: revenue $0.7 million, net income Net loss was $22.0 million.
  - Period: the quarter ended September 30, 2023
  - Revenue: $0.7 million
  - Net income: Net loss was $22.0 million
  - Result: reported results
  source text: Revenue was $0.7 million for the three months ended September 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1672688/000162828023038977/0001628280-23-038977-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.